Please assess the completion status of the following clinical trial:

Trial Title: Tramadol Versus Celecoxib for Reducing Pain in Outpatient Hysteroscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* women referred to the outpatient hysteroscopy in Cairo university hospitals~* Consent to the procedure~Exclusion Criteria:~* Premenstrual patients~* Patients with missed periods~* Known cardiac disease~* Known gastritis or peptic ulcer~* Known allergy to Tramadol or Celecoxib

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tramadol (Type: ACTIVE_COMPARATOR): Women will receive Tramadol 100mg 1 hour before the procedure.
- Celecoxib (Type: ACTIVE_COMPARATOR): Women will receive Celecoxib 200mg 1 hour before the procedure.
- Placebo (Type: PLACEBO_COMPARATOR): Women will receive a placebo 1 hour before the procedure.

Based on this trial design, predict the completion outcome and termination type (if applicable).